Viridian Therapeutics, Inc.\DE
SEC 4 · Filed
0001193125-26-001097Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Dec 31, 2025
- Security
- Common Stock
- Shares
-
2,272
- Price per share
-
31.16
Structured facts
{
"code": "S",
"date": "2025-12-31",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Consists of shares purchased under the Issuer\u0027s employee stock purchase plan."
},
"owners": [
{
"cik": "0002010978",
"name": "Tousignant Jennifer",
"roles": [
"officer"
],
"title": "Chief Legal Officer"
}
],
"ownership": "D",
"post_shares": "0",
"price": "31.16",
"row": 1,
"rule_10b5_1": "false",
"security": "Common Stock",
"shares": "2272",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}